This broker thinks the A2 Milk (ASX:A2M) share price is heading to $7.70

Bell Potter thinks the A2 Milk share price is great value…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The A2 Milk Company Ltd (ASX: A2M) share price is having a year to forget.

Since the start of 2021, the embattled infant formula company's shares are down a disappointing 52%.

A cute young girl with curly hair sips a glass of milk through a straw with a smile on her face.

Image source: Getty Images

Is the A2 Milk share price weakness a buying opportunity?

According to a note out of Bell Potter, its analysts remain positive on the A2 Milk share price.

This morning the broker retained its buy rating and $7.70 price target on the company's shares.

Based on the current A2 Milk share price of $5.61, this implies potential upside of 37% over the next 12 months.

What did the broker say?

Bell Potter has been looking at industry and export data and remains positive.

The broker highlights that Australia-China exports, which are a daigou proxy, were up 8% in October. And while it notes that Christchurch exports to China were down 33% year on year in October, they remain up 10% year to date over the same period last year.

Commenting on the latter, its analysts said: "Based on the four month lead time in shipments to revenues, early indicators of 2H22e would imply activity ~7% higher than 1H22 levels."

Finally, Bell Potter notes that overall China infant formula imports continue to demonstrate double digit year on year declines, with volumes falling 21% year on year in September. However, it feels that volumes may have formed a bottom, and is encouraged by a noticeable spike in export to Hong Kong (CBEC). The broker feels this is "notable and coincides with a similar notable uptick in volumes moving into China from Hong Kong."

Remaining buy-rated

In light of the above, Bell Potter is holding firm with its buy rating on the A2 Milk share price.

The broker concluded: "There is no change to our Buy rating. We see the scope for EPS to double by FY26e, if A2M can execute on the China offline expansion strategy, while recovering 50% of the lost sales (from FY20-21) in English label IMF. Exiting the loss making US assets or navigating a turnaround at the MVM asset would likely accelerate this turnaround. We do not see the current share price as reflecting this potential."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A woman holds her finger to the side of her face and looks upwards as she thinks about something.
Broker Notes

4 ASX shares at 52-week lows: Buy, hold, or sell?

Here's what the experts think.

Read more »

A female athlete in green spandex leaps from one cliff edge to another representing 3 ASX shares that are destined to rise and be great
Broker Notes

Up 57% since February, why Telix shares could keep leaping higher in 2026

A leading analyst believes investors are undervaluing Telix shares. But why?

Read more »

A happy young woman in a red t-shirt hold up two delicious burritos.
Broker Notes

Guzman Y Gomez shares just sank to new all-time lows. Time to buy?

A leading analyst provides his outlook for the battered Guzman Y Gomez share price.

Read more »